Integra LifeSciences Holdings Corp buy Wells Fargo & Company
Start price
05.12.23
/
50%
€37.80
Target price
05.12.24
€45.24
Performance (%)
-57.94%
Price
04.10.24
€15.50
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Integra LifeSciences Holdings Corp is performing very badly with a performance of -57.94%. This prediction currently runs until 05.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Integra LifeSciences Holdings Corp | -2.516% | -2.516% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Integra LifeSciences Holdings Corp diskutieren
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Ratings data for IART provided by MarketBeat